2.53
price up icon2.02%   0.05
after-market Dopo l'orario di chiusura: 2.52 -0.010 -0.40%
loading
Precedente Chiudi:
$2.48
Aprire:
$2.47
Volume 24 ore:
238.28K
Relative Volume:
2.39
Capitalizzazione di mercato:
$26.18M
Reddito:
$1.65M
Utile/perdita netta:
$-5.66M
Rapporto P/E:
-2.1441
EPS:
-1.18
Flusso di cassa netto:
-
1 W Prestazione:
-9.64%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$2.36
$2.70
Intervallo di 1 settimana:
Value
$2.36
$3.0837
Portata 52W:
Value
$2.36
$14.09

20 20 Biolabs Inc Stock (AIDX) Company Profile

Name
Nome
20 20 Biolabs Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
AIDX's Discussions on Twitter

Compare AIDX vs ABT, SYK, MDT, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
AIDX
20 20 Biolabs Inc
2.53 26.18M 1.65M -5.66M 0 -1.18
Medical Devices icon
ABT
Abbott Laboratories
108.03 187.72B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
336.77 128.88B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
87.14 111.88B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
69.13 102.58B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
81.81 47.52B 6.07B 1.06B 1.34B 1.8063

20 20 Biolabs Inc Borsa (AIDX) Ultime notizie

pulisher
Mar 12, 2026

20/20 Biolabs, Inc. Revenue Breakdown – NASDAQ:AIDX - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

20/20 BioLabs provides update on protein biomarket technology for MCED - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies - Bitget

Mar 12, 2026
pulisher
Mar 10, 2026

Jonathan Cohen Discloses Investment at 20/20 Biolabs with 16.8% Stake - TradingView

Mar 10, 2026
pulisher
Mar 04, 2026

20/20 Biolabs (AIDX) CEO awarded 352,936-share stock option grant - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research

Mar 04, 2026
pulisher
Mar 04, 2026

20/20 Biolabs (AIDX) 10K Form and SEC Filings 2026 - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 04, 2026
pulisher
Mar 04, 2026

20/20 Biolabs Inc. (AIDX) Price To Cash Flow - Zacks Investment Research

Mar 04, 2026
pulisher
Mar 03, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

20/20 Biolabs Inc. (AIDX) Net Income (Quarterly) - Zacks Investment Research

Mar 03, 2026
pulisher
Mar 03, 2026

AIDX News Today | Why did 20/20 Biolabs stock go down today? - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

20/20 Biolabs (AIDX) Stock Price, News & Analysis - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Cash From Operations (TTM) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

Number of employees of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Cash From Financing (TTM) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Dividend Yield (TTM) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Shareholders Equity (Quarterly) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Profit Margin (Quarterly) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) Revenue (TTM) - Zacks Investment Research

Mar 01, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) - Zacks Investment Research

Mar 01, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) Total Assets (Quarterly) - Zacks Investment Research

Mar 01, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) Ps Ratio (TTM) - Zacks Investment Research

Mar 01, 2026
pulisher
Feb 28, 2026

20/20 Biolabs, Inc. Common Stock (AIDX) Competitors - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

20/20 Biolabs, Inc. Common Stock (AIDX) AI-Powered Stock Analysis - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

AIDX News Today: Stay Updated with the Latest 20/20 Biolabs, Inc. Common Stock News in Real Time - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

Why Is 20/20 Biolabs, Inc. Common Stock (AIDX) Stock Up Today? - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

20/20 Biolabs, Inc. Common Stock (AIDX) Fundamental Analysis - Meyka

Feb 28, 2026
pulisher
Feb 27, 2026

What is the current Price Target and Forecast for 20/20 Biolabs Inc. (AIDX) - Zacks Investment Research

Feb 27, 2026
pulisher
Feb 26, 2026

Operating income of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Non-operating income (total) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Diluted earnings per share (diluted EPS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Net income before discontinued operations of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

AIDX Price History for 20/20 Biolabs Stock - Barchart.com

Feb 26, 2026
pulisher
Feb 26, 2026

Non-controlling/minority interest of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Equity in earnings of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Taxes of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Operating expenses (excl. COGS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Diluted net income available to common stockholders of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

After tax other income/expense of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Gross profit of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Dilution adjustment of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Pretax income of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

Total liabilities of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total debt of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total liabilities & shareholders' equities of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Net debt of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total equity of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

20/20 Biolabs, Inc. Cash Flow – BOATS:AIDX - TradingView

Feb 26, 2026

20 20 Biolabs Inc Azioni (AIDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$93.20
price up icon 0.66%
medical_devices STE
$214.57
price up icon 1.05%
$64.24
price down icon 1.56%
medical_devices PHG
$27.79
price down icon 1.66%
$70.77
price up icon 0.63%
medical_devices EW
$81.81
price down icon 3.31%
Capitalizzazione:     |  Volume (24 ore):